The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis episode artwork

EPISODE · Jul 15, 2022 · 38 MIN

The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

from Investors' Chronicle

On this week's show, we get the breakdown on GSK spinoff Haleon which is set to list next week.Then Arthur Sants takes a fascinating dive into the business of psychedelic drugs, and whether they can be the future of depression and anxiety treatment.Finally, the panel look into the potential European gas crisis, with the threat of Russian pipelines being turned off hanging over the continent.Dan Jones host Alex Newman, Alex Hamer, Mark Robinson and Arthur Sants.Timestamps:00:00 - Intro01:00 - News roundup02:49 - GSK spinoff Haleon listing previewed13:24 - Can psychedelics be the future of anxiety treatment?23:16 - A looming European gas crisis?Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jul 15, 2022

Embed this episode

Ready to play

The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

0:00 38:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Investors' Chronicle?

This episode is 38 minutes long.

When was this Investors' Chronicle episode published?

This episode was published on July 15, 2022.

Can I download this Investors' Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!